Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Exact Sciences Corporatio...

    NASDAQ: EXAS · Real-Time Price · USD
    53.29
    -0.23 (-0.43%)
    At close: Jun 16, 2025, 3:59 PM
    52.51
    -1.46%
    After-hours: Jun 16, 2025, 07:59 PM EDT

    Exact Sciences Statistics

    Share Statistics

    Exact Sciences has 188.64M shares outstanding. The number of shares has increased by 0.66% in one year.

    Shares Outstanding

    n/a
    		 188.64M

    Shares Change (YoY)

    n/a
    		 0.66%

    Shares Change (QoQ)

    n/a
    		 0.37%

    Owned by Institutions (%)

    n/a
    		 99.57%

    Shares Floating

    n/a
    		 185.85M

    Failed to Deliver (FTD) Shares

    n/a
    		 22,776

    FTD / Avg. Volume

    n/a
    		 0.81%

    Short Selling Information

    The latest short interest is 10.67M, so 5.66% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 10.67M

    Short % of Shares Out

    n/a
    		 5.66%

    Short % of Float

    n/a
    		 6.47%

    Short Ratio (days to cover)

    n/a
    		 2.97

    Valuation Ratios

    The PE ratio is -10.06 and the forward PE ratio is 145.86. Exact Sciences's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 -10.06

    Forward PE

    n/a
    		 145.86

    PS Ratio

    n/a
    		 3.75

    Forward PS

    n/a
    		 2.3

    PB Ratio

    n/a
    		 4.31

    P/FCF Ratio

    n/a
    		 138.84

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Exact Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.15, with a Debt / Equity ratio of 1.15.

    Current Ratio

    n/a
    		 2.15

    Quick Ratio

    n/a
    		 1.92

    Debt / Equity

    n/a
    		 1.15

    Debt / EBITDA

    n/a
    		 -3.49

    Debt / FCF

    n/a
    		 36.95

    Interest Coverage

    n/a
    		 -32.8

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $399,835.8

    Profits Per Employee

    n/a
    		 $-149,109.71

    Employee Count

    n/a
    		 6,900

    Asset Turnover

    n/a
    		 0.47

    Inventory Turnover

    n/a
    		 5.17

    Taxes

    Income Tax

    n/a
    		 -7.3M

    Effective Tax Rate

    n/a
    		 0.7%

    Stock Price Statistics

    The stock price has increased by 27.79% in the last 52 weeks. The beta is 0.98, so Exact Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.98

    52-Week Price Change

    n/a
    		 27.79%

    50-Day Moving Average

    n/a
    		 50.73

    200-Day Moving Average

    n/a
    		 55.99

    Relative Strength Index (RSI)

    n/a
    		 47.07

    Average Volume (20 Days)

    n/a
    		 2,814,404

    Income Statement

    In the last 12 months, Exact Sciences had revenue of 2.76B and earned -1.03B in profits. Earnings per share was -5.59.

    Revenue

    n/a
    		 2.76B

    Gross Profit

    n/a
    		 1.92B

    Operating Income

    n/a
    		 -1.05B

    Net Income

    n/a
    		 -1.03B

    EBITDA

    n/a
    		 -788.73M

    EBIT

    n/a
    		 -1B

    Earnings Per Share (EPS)

    n/a
    		 -5.59
    Full Income Statement

    Balance Sheet

    The company has 600.89M in cash and 2.75B in debt, giving a net cash position of -2.15B.

    Cash & Cash Equivalents

    n/a
    		 600.89M

    Total Debt

    n/a
    		 2.75B

    Net Cash

    n/a
    		 -2.15B

    Retained Earnings

    n/a
    		 -4.5B

    Total Assets

    n/a
    		 5.71B

    Working Capital

    n/a
    		 867.88M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 210.54M and capital expenditures -135.99M, giving a free cash flow of 74.55M.

    Operating Cash Flow

    n/a
    		 210.54M

    Capital Expenditures

    n/a
    		 -135.99M

    Free Cash Flow

    n/a
    		 74.55M

    FCF Per Share

    n/a
    		 0.4
    Full Cash Flow Statement

    Margins

    Gross margin is 69.55%, with operating and profit margins of -38.01% and -37.29%.

    Gross Margin

    n/a
    		 69.55%

    Operating Margin

    n/a
    		 -38.01%

    Pretax Margin

    n/a
    		 -37.56%

    Profit Margin

    n/a
    		 -37.29%

    EBITDA Margin

    n/a
    		 -28.59%

    EBIT Margin

    n/a
    		 -38.01%

    FCF Margin

    n/a
    		 2.7%

    Dividends & Yields

    EXAS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for EXAS is $71, which is 32.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $71

    Price Target Difference

    n/a
    		 32.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 21
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.94

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist